header
May 7, 2018

In This Issue
IN THE SPOTLIGHT
MMA Listening Session in Presque Isle on Tuesday, May 15 6-8pm
Jeffrey Barkin, MD, DFAPA Receives MAPP Lifetime Achievement Award
Update Will Change Buprenorphine MME Display in Most State PMPs
New Scrutiny for an Old Drug
New Interactive Online Course Ups Physicians’ Nutrition Knowledge, Supports Patients in Diabetes Prevention
Consumer and Healthcare Groups File Suit for Medicaid Expansion Implementation
Maine Physicians Participate in Regional State Medical Society Meeting in Connecticut Last Weekend
APM Set Forth for Opioid-use Disorder Treatment
The Honorable George J. Mitchell to Keynote MMA's 165th Annual Session
128th MAINE LEGISLATURE
Legislative Report: Is This a Wrap-up?
UPCOMING EVENTS
Introduction to LEAN in Healthcare: Full-Day Workshop on Tuesday, May 8
MaineHealth MORE Conference - Managing the Opioid Response Effort - May 17th
Maine Chapter, American College of Surgeons Annual Meeting in Kennebunkport, ME - May 18-20
Monday, May 21 in Brewer: Next Steps in Addressing Maine's Opioid Crisis
Inspiring Hope: How to Support Recovery Ready Communities - May 24 Conference
One River, One Ocean: June 2-14, 2018
MCMI Training Programs - Level 1 and Level 2 - June 22
New Free CME on Alzheimer's Risk, Detection, and Management
Peer Navigation Program from Facing Our Risk of Cancer Empowered (FORCE)
Online Learning Opportunities Offering CME Credits - from the Northern New England Practice Transformation Network
Northern New England Society of Addiction Medicine 2018 Annual Conference & Meeting - Nov 2-3
HEALTHCARE EMPLOYMENT OPPORTUNITIES
Internal Medicine Outpatient Physician Opportunity
Ob/Gyn Physician Opportunity
Outpatient Internal Medicine Physician – Bangor, Maine
Family Practice Physician - Bucksport Regional Health Center
Relocate to Beautiful Southwestern Maine - Medical Director/Family Practice Physician
Psychiatry Faculty, Division of Child & Adolescent Psychiatry
Psychiatric Medical Director
Maine's Largest FQHC in need of Physician for Geriatric Program
Multiple Family Med Opportunities in Beloved Community Health Centers
Outpatient Only - Internal Medicine with Loan Repayment & Sign-on Bonus
Internal Medicine Outpatient Physician
Clinical Cardiology Opportunity
Opportunities at the VA for Volunteer Physicians

 
Search Back Issues





 



Follow Us:
New Scrutiny for an Old Drug

The latest drug to come under FDA scrutiny is the generic gabapentin, the 9th most prescribed medication in the US. Commissioner Scott Gottlieb has stated, “I don’t want to be sitting here 5 or 10 years from now lamenting that we didn’t take more aggressive action.” Many physicians are not aware that people are using gabapentin, often mixed with opioids and other substances, to achieve a modified mental status. The AP reports that, according to medical journal articles, 15 to 25% of opioid users also use gabapentin. While it is not considered addictive, it has featured in a rising number of overdoses.

Some states are adding gabapentin to their tracking databases, and Kentucky has classified it as a “scheduled substance.” It appears that increased prescribing levels originated at a time when the drug’s original manufacturer began aggressive marketing. In 2004 the company, Warner-Lambert, pleaded guilty to charges of promoting gabapentin for a wide range of uses not approved by the FDA and paid over $430 million in settlement of the charges. Warner-Lambert was purchased by Pfizer in 2000.


< Previous Article | Next Article >

[ return to top ]

To ensure delivery of Maine Medicine Weekly Update,
please add 'info@mainemed.com' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm


Unsubscribe here

For more information or to contact us directly, please visit www.mainemed.com | ©